![](https://bigul.co/stock-screener/assetData/img/bar-shape.png)
![](https://bigul.co/stock-screener/assetData/img/pointer.png)
Bullish Moving Averages
11
Bearish Moving Averages
5
Back Stocks profile
Open Price
623.80Prev. Close
587.7500Volume
44197.00Value
27450756.70Market Cap Cr
5628.80
Price to Earnings
26.00
Price to Book Value
3.20
Dividend Yield
0.30
PE to Growth
-1.00
Op Revenue TTM Cr
1852.62
Net Profit TTM Cr
216.90
Cash From Operating Activity Cr
216.36
Return on Equity %
12.34
EMA & SMA
Bullish Moving Averages
11
Bearish Moving Averages
5
DELIVERY AND VOLUME
03 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
644.07
Second Resistance
665.53
Third Resistance
678.07
First Support
610.07
Second Support
597.53
Third Support
576.07
Relative Strength Index
54.88
Money Flow Index
66.02
MACD
15.66
MACD Signal
17.28
Average True Range
25.56
Average Directional Index
16.57
Rate of Change (21)
8.19
Rate of Change (125)
23.2
Commodity Channel Index
61
Williams %R
-56.6
BETA
1 Month
1.08
3 Month
1.07
1 Year
0.94
3 Year
PRICE CHANGE ANALYSIS
1 Week
Low
High
603.45
662.8
1 Month
Low
High
497.05
662.8
3 Months
Low
High
430
662.8
6 Months
Low
High
399.55
662.8
1 Year
Low
High
320.3
662.8
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Credit Rating
Reaffirmation of Credit Rating for long-term bank loan facilitiesAarti Pharmalabs Ltd - 543748 - Closure of Trading Window
Intimation of Closure of Trading WindowAarti Pharmalabs Ltd - 543748 - Announcement Under Regulation 30 Of SEBI LODR, 2015
Closure of manufacturing activities at the Company''s Dombivli PlantAarti Pharmalabs Ltd - 543748 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2024Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Q4 FY 24 Earnings Conference CallAarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Recording of the Earnings Conference Call for Q4 FY 24/ FY 24Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Audited Financial Results for the Quarter and Year ended March 31, 2024Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation
Q4 FY 24 /FY 24 Investor PresentationAarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Smt. Nehal Garewal as Non-Executive Non-Independent Director of the CompanyThe latest market price of Aarti Pharmalabs Ltd. on NSE was Rs. 621.10 as of today.
The opening share price of Aarti Pharmalabs Ltd. was Rs. 623.80 as of today.
The 52-week high share price of Aarti Pharmalabs Ltd. was Rs. 662.80.
The 52 week low share price of Aarti Pharmalabs Ltd. was Rs. 320.30.
Aarti Pharmalabs Ltd. has a market cap of Rs. 5628.80 crore as of today. Please refer to the Fundamentals section for further details.
The PE ratio of Aarti Pharmalabs Ltd. is -1.00. Please refer to the Fundamentals section for further details.
The operating revenue for Aarti Pharmalabs Ltd. in the last FY was Rs. 1852.62 crore. Please refer to the Financials section for further details.
The Net Profit for Aarti Pharmalabs Ltd. in the last FY was Rs. 216.90 crore. Please refer to the Financials section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
The latest dividend declared by Aarti Pharmalabs Ltd. was on 2024-02-16 for Rs. 2 per share. According to today’s share price, the dividend yield of Aarti Pharmalabs Ltd. stands at 0.30. Please refer to the Corporate Actions section for further details.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Aarti Pharmalabs Ltd..